From lab to clinic, NeuroBionics is redefining neuromodulation with flexible, vascular‑based neural interfaces. In this interview, co‑founder Nicolette Driscoll shares her journey, the technical breakthroughs behind their evStim device, and how they’re pushing neurotechnology forward.

Sam Hosovsky, CEO of uCat, shares his journey into neurotechnology and how his company is transforming brain-computer interface (BCI) development through VR-based training and avatar embodiment. Discover how uCat is helping redefine clinical adoption of BCIs.